$1.33
+0.06 (+4.72%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,244.4% upside
Low Target
$13.09
Average Target
$17.88
High Target
$22.82
Current Price
$1.33
Current
$1.33
$1.33
Target
$17.88
$17.88
$13.09
$17.88 avg
$22.82
Scenario Analysis
Bear Case
$13.09
884.2%
Low target
Base Case
$17.88
+1,244.4%
Avg target
Bull Case
$22.82
+1,615.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$21.79
-93.9% from high
52-Week Low
$8.54
+-84.4% from low
Target vs 52W High
$17.88
-17.9% vs high
Next Earnings Report
Feb 26, 2026 · After Market Close
9d
until earnings
EPS Est: $-0.04
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 82% | $369.21 | -32.0% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -27.0% |
| A | Buy | 29 | 72% | $64.69 | -50.1% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -55.8% |
| MTD | Hold | 21 | 43% | $170.43 | -87.6% |
| WAT | Buy | 25 | 56% | $189.60 | -50.3% |
| ILMN | Hold | 26 | 50% | $169.36 | +41.5% |
| WST | Strong Buy | 23 | 78% | $136.24 | -45.3% |